Home>
US Stocks>
Immunocore Holdings Plc-adr

Immunocore Holdings Plc-adr share price today

(IMCR)

Immunocore Holdings Plc-adr share price is $32.22 & ₹2,728.55

$32.22

▲

-0.27

(-0.83%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Immunocore Holdings Plc-adr share price in Dollar and Rupees. Guide to invest in Immunocore Holdings Plc-adr from India. Also see the sentimental analysis on Indian investors investing in Immunocore Holdings Plc-adr. Get details on the Indian mutual funds that are investing in Immunocore Holdings Plc-adr. Get Analyst recommendations and forecasts along with all the Immunocore Holdings Plc-adr's financials.

Immunocore Holdings Plc-adr share price movements

$32.11
$33.24
$32.22
0.34%
Downside
Day's Volatility :3.38%
Upside
3.05%
$29.72
$76.98
$32.22
7.76%
Downside
52 Weeks Volatility :61.39%
Upside
58.14%

Immunocore Holdings Plc-adr Returns

Period	Immunocore Holdings Plc-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.59%	-6.2%	0.0%
6 Months	-24.53%	1.7%	0.0%
1 Year	-38.21%	11.6%	0.0%
3 Years	17.8%	12.9%	-18.1%

Immunocore Holdings Plc-adr Key Statistics

in dollars & INR

Market Capitalization	$1.6B
Revenue TTM	$296.3M
EBITDA	$-64.9M
Earnings Per Share (EPS)	$-0.95
Profit Margin	-15.88%
Quarterly Earnings Growth YOY	8.22%
Return On Equity TTM	-12.83%

How to invest in Immunocore Holdings Plc-adr from India?

It is very easy for Indian residents to invest directly in Immunocore Holdings Plc-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunocore Holdings Plc-adr stock in both rupees (INR) and dollars (USD). Search for Immunocore Holdings Plc-adr or IMCR on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunocore Holdings Plc-adr or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunocore Holdings Plc-adr shares which would translate to 0.026 fractional shares of Immunocore Holdings Plc-adr as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Immunocore Holdings Plc-adr

67%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Immunocore Holdings Plc-adr on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 67% more investors are searching Immunocore Holdings Plc-adr in the last 30 days versus the previous period.

Global Institutional Holdings in Immunocore Holdings Plc-adr

Wellington Management Company LLP
14.09%
T. Rowe Price Investment Management,Inc.
12.99%
RTW INVESTMENTS, LLC
9.73%
FMR Inc
9.67%
PRIMECAP Management Company
4.94%
T. Rowe Price Associates, Inc.
4.31%

Analyst Recommendation on Immunocore Holdings Plc-adr

Buy

91%Buy

8%Hold

0%Sell

Based on 24 Wall street analysts offering stock ratings for Immunocore Holdings Plc-adr(by analysts ranked 0 to 5 stars)

Based on 24 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immunocore Holdings Plc-adr

What analysts predicted

Upside of 62.99%

Current:

$32.22

Target:

$52.51

Insights on Immunocore Holdings Plc-adr

Increasing Revenue
Revenue is up for the last 3 quarters, 70.50M → 80.24M (in $), with an average increase of 6.3% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -26.41M → 8.73M (in $), with an average increase of 117.2% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 85.9%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 34.4%

Immunocore Holdings Plc-adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.0M	-
Net Income	$-90.7M	-
Net Profit Margin	-302.82%	-

	FY19	Y/Y Change
Revenue	$33.6M	↑ 8.52%
Net Income	$-136.1M	↑ 45.09%
Net Profit Margin	-404.89%	↓ 102.07%

	FY20	Y/Y Change
Revenue	$40.5M	↑ 17.32%
Net Income	$-99.5M	↓ 28.71%
Net Profit Margin	-246.04%	↑ 158.85%

	FY21	Y/Y Change
Revenue	$35.3M	↓ 11.93%
Net Income	$-175.0M	↑ 77.51%
Net Profit Margin	-495.94%	↓ 249.9%

	FY22	Y/Y Change
Revenue	$175.0M	↑ 441.99%
Net Income	$-50.2M	↓ 68.66%
Net Profit Margin	-28.68%	↑ 467.26%

	FY23	Y/Y Change
Revenue	$315.8M	↑ 73.53%
Net Income	$-70.0M	↑ 34.11%
Net Profit Margin	-22.17%	↑ 6.51%

	Q2 FY23	Q/Q Change
Revenue	$60.3M	↑ 7.24%
Net Income	$-17.8M	↓ 15.69%
Net Profit Margin	-29.47%	↑ 8.02%

	Q3 FY23	Q/Q Change
Revenue	$77.7M	↑ 31.11%
Net Income	$2.9M	↓ 116.45%
Net Profit Margin	3.7%	↑ 33.17%

	Q4 FY23	Q/Q Change
Revenue	$133.7M	↑ 68.68%
Net Income	$-33.4M	↓ 1240.71%
Net Profit Margin	-25.01%	↓ 28.71%

	Q1 FY24	Q/Q Change
Revenue	$89.6M	↓ 33.26%
Net Income	$-31.1M	↓ 7.5%
Net Profit Margin	-34.66%	↓ 9.65%

	Q2 FY24	Q/Q Change
Revenue	$75.4M	↑ 6.95%
Net Income	$-11.6M	↓ 52.46%
Net Profit Margin	-15.41%	↑ 19.25%

	Q3 FY24	Q/Q Change
Revenue	$80.2M	↑ 6.43%
Net Income	$8.7M	↓ 175.21%
Net Profit Margin	10.89%	↑ 26.3%

	FY18	Y/Y Change
Total Assets	$247.9M	-
Total Liabilities	$176.3M	-

	FY19	Y/Y Change
Total Assets	$243.1M	↓ 5.17%
Total Liabilities	$223.7M	↑ 22.76%

	FY20	Y/Y Change
Total Assets	$264.9M	↑ 6.22%
Total Liabilities	$190.5M	↓ 16.99%

	FY21	Y/Y Change
Total Assets	$401.5M	↑ 53.03%
Total Liabilities	$173.3M	↓ 8.19%

	FY22	Y/Y Change
Total Assets	$530.2M	↑ 44.32%
Total Liabilities	$190.8M	↑ 20.38%

	FY23	Y/Y Change
Total Assets	$597.0M	↑ 37.08%
Total Liabilities	$228.2M	↑ 45.54%

	Q2 FY23	Q/Q Change
Total Assets	$556.1M	↑ 2.28%
Total Liabilities	$205.9M	↑ 4.25%

	Q3 FY23	Q/Q Change
Total Assets	$700.6M	↑ 28.19%
Total Liabilities	$260.5M	↑ 28.71%

	Q4 FY23	Q/Q Change
Total Assets	$755.8M	↑ 5.76%
Total Liabilities	$288.8M	↑ 8.7%

	Q1 FY24	Q/Q Change
Total Assets	$1.3B	↑ 66.5%
Total Liabilities	$806.4M	↑ 178.08%

	Q2 FY24	Q/Q Change
Total Assets	$1.0B	↑ 2.96%
Total Liabilities	$664.2M	↑ 4.69%

	Q3 FY24	Q/Q Change
Total Assets	$1.1B	↑ 5.99%
Total Liabilities	$706.8M	↑ 6.41%

	FY18	Y/Y Change
Operating Cash Flow	$-21.1M	↓ 72.71%
Investing Cash Flow	$73.5M	↓ 703.68%
Financing Cash Flow	$127.9K	↓ 99.47%

	FY19	Y/Y Change
Operating Cash Flow	$-132.7M	↑ 509.74%
Investing Cash Flow	$-5.4M	↓ 107.13%
Financing Cash Flow	$72.2M	↑ 54481.19%

	FY20	Y/Y Change
Operating Cash Flow	$-81.4M	↓ 40.25%
Investing Cash Flow	$627.3K	↓ 111.29%
Financing Cash Flow	$155.7M	↑ 110.32%

	FY21	Y/Y Change
Operating Cash Flow	$-172.6M	↑ 114.2%
Investing Cash Flow	$-488.3K	↓ 178.59%
Financing Cash Flow	$367.5M	↑ 138.27%

	FY22	Y/Y Change
Operating Cash Flow	$-38.1M	↓ 75.9%
Investing Cash Flow	$234.9K	↓ 152.59%
Financing Cash Flow	$168.3M	↓ 49.96%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.0M	↓ 127.2%
Investing Cash Flow	$3.4M	↑ 0.0%
Financing Cash Flow	$9.3M	↑ 196.1%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.7M	↓ 360.35%
Investing Cash Flow	$2.7M	↓ 20.88%
Financing Cash Flow	$9.7M	↑ 6.11%

Immunocore Holdings Plc-adr Technicals Summary

Sell

Neutral

Buy

Immunocore Holdings Plc-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immunocore Holdings Plc-adr Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunocore Holdings Plc-adr	4.23%	-24.53%	-38.21%	17.8%	-18.02%
Regeneron Pharmaceuticals, Inc.	-8.02%	-24.21%	-7.13%	21.97%	104.79%
Biontech Se	7.55%	14.34%	18.7%	-58.12%	380.92%
Alnylam Pharmaceuticals, Inc.	-6.28%	66.39%	48.51%	42.94%	104.44%
Vertex Pharmaceuticals Incorporated	-1.5%	-3.58%	31.51%	127.12%	108.61%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunocore Holdings Plc-adr	NA	NA	NA	-0.56	-0.13	-0.05	NA	7.55
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunocore Holdings Plc-adr	Buy	$1.6B	-18.02%	NA	-15.88%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	104.79%	18.55	33.61%
Biontech Se	Buy	$28.9B	380.92%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	104.44%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	108.61%	32.84	-4.51%

About Immunocore Holdings Plc-adr

immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. its world-leading t cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. immunocore has established a robust technology platform which combines monoclonal t cell receptor (mtcr) targeting technology with an effector technology, anti-cd3 scfv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic t cells. immunocore is developing a portfolio of products from the platform, called immtacs, for the treatment of cancer, chronic infectious disease and diabetes.

Organization	Immunocore Holdings Plc-adr
Employees	497
CEO	Dr. Bahija Jallal Ph.D.
Industry	Services

Important FAQs about investing in Immunocore Holdings Plc-adr from India :

What is Immunocore Holdings Plc-adr share price today?

Immunocore Holdings Plc-adr (IMCR) share price today is $32.22.

Can Indians buy Immunocore Holdings Plc-adr shares?

Yes, Indians can invest in the Immunocore Holdings Plc-adr (IMCR) from India.

With INDmoney, you can buy Immunocore Holdings Plc-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunocore Holdings Plc-adr at zero transaction cost.

How can I buy Immunocore Holdings Plc-adr shares from India?

It is very easy to buy Immunocore Holdings Plc-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunocore Holdings Plc-adr be purchased?

Yes, you can buy fractional shares of Immunocore Holdings Plc-adr with INDmoney app.

What are the documents required to start investing in Immunocore Holdings Plc-adr stocks?

To start investing in Immunocore Holdings Plc-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.